bpc-157 clinical trials human safety trial humans BPC-157: What you need to know before you try bpc-157 human clinical trial evidence

Animals developed persistent esophagitis with hemorrhagic lesions, thinned epithelium, and chronically reduced sphincter pressures lasting up to 20 months

Though the recommended doses are not expected to cause adverse effects for the infant, there are no human studies available to assess the risks

It can make it harder to know which compound is helping, which one is causing side effects, and how the overall protocol should be adjusted

Lee H, Bennett AM

A breastfeeding mothers B12 levels directly affect the babys intake, especially in the early months

injectable and systemic anti-aging claims are less established and face safety or evidence gaps